全部股東
股東類型
- 機構投資者72.75%
- 個人與內幕人士9.17%
- 創投/私募6.71%
- 對沖基金4.88%
- 其他6.49%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Jonathan LimCo-Founder, Chairman & CEO | 9.32% | 3,235.56 萬 | 1.09% | +0 | 15/04/2026 |
Frazier Life Sciences Management, LP | 7.05% | 2,467.52 萬 | 0.94% | +194.58 萬 | 31/03/2026 |
T. Rowe Price Group, Inc. | 6.60% | 2,307.50 萬 | 0.89% | +686.01 萬 | 31/03/2026 |
BlackRock, Inc. | 6.05% | 2,115.41 萬 | 0.44% | +100.27 萬 | 30/06/2026 |
VR Management, LLC | 4.64% | 1,621.62 萬 | 0.63% | -16.66 萬 | 15/04/2026 |
RTW Investments, LP | 4.62% | 1,615.72 萬 | 4.57% | +1,601.05 萬 | 31/03/2026 |
Vanguard Capital Management, LLC | 3.75% | 1,310.02 萬 | 0.37% | +31.25 萬 | 30/06/2026 |
Novartis AG | 3.55% | 1,230.77 萬 | 0.79% | +0 | 31/12/2024 |
State Street Investment Management | 3.48% | 1,218.46 萬 | 0.49% | +288.45 萬 | 30/06/2026 |
Vivo Capital, LLC | 3.47% | 1,215.15 萬 | 0.21% | +287.81 萬 | 31/03/2026 |
Artal Group S.A. | 3.26% | 1,139.78 萬 | 0.36% | +15.35 萬 | 30/06/2026 |
Logos Global Management, L.P. | 3.19% | 1,115.00 萬 | 1.39% | -185.00 萬 | 31/03/2026 |
Paradigm Biocapital Advisors LP | 2.97% | 1,039.27 萬 | 2.01% | -376.64 萬 | 31/03/2026 |
Arch Venture Partners, L.P. | 2.03% | 709.16 萬 | 1.86% | -396.40 萬 | 31/03/2026 |
Geode Capital Management, LLC | 1.86% | 650.14 萬 | 0.07% | +50.53 萬 | 30/06/2026 |
Cormorant Asset Management, LP | 1.66% | 580.00 萬 | -- | +580.00 萬 | 31/03/2026 |
Affinity Asset Advisors, LLC | 1.50% | 525.00 萬 | 0.22% | -10.00 萬 | 30/06/2026 |
Balyasny Asset Management L.P. | 1.47% | 514.40 萬 | 1.44% | +504.59 萬 | 31/03/2026 |
Janus Henderson Group Ltd. | 1.06% | 371.10 萬 | -- | +371.10 萬 | 31/03/2026 |
5AM Venture Management, LLC | 1.00% | 348.60 萬 | 0.91% | -191.94 萬 | 31/03/2026 |